DataString Consulting Company Logo
DataString Consulting Company Logo
Vascular Closure Devices Market
Home»Top Market Reports»Vascular Closure Devices Market

Vascular Closure Devices Market

Author: Debadatta Patel - Senior Consultant, Report ID - DS1801091, Published - January 2025

Segmented in Product Type (Active Closure, Passive Closure), Access (Femoral Arterial Access, Radial Arterial Access), End User, Procedure and Regions - Global Industry Analysis, Size, Share, Trends, and Forecast 2024 – 2034

Share this report:

Global Vascular Closure Devices
Market Outlook

The market for Vascular Closure Devices (VCDs) is thriving due to the increasing prevalence of diseases worldwide and the rise in interventional procedures that are reshaping post surgical care practices globally. The market, for Vascular closure devices was estimated at $1.9 billion in 2024. It is anticipated to increase to $2.5 billion by 2030 with projections indicating a growth to around $3.2 billion by 2035. This expansion represents a compound annual growth rate (CAGR) of 4.9% over the forecast period. VCDs play a role in ensuring prompt hemostasis after catheterization procedures and showcase how technology is revolutionizing the field of medicine. These devices offer an efficient alternative to traditional manual compression methods and are driving a shift, towards more patient focused and time saving healthcare approaches.


Medical professionals use a variety of hemostatic devices known as Vascular Closure Devices (or VCD’s) to close arterial punctures in patients following catheterization procedures to ensure a safe recovery after surgery and prevent issues like hematoma and pseudoaneurysms, from occurring.


Market Size Forecast & Key Insights

2019
$1.9B2024
2029
$3B2034

Absolute Growth Opportunity = $1.2B

The Vascular Closure Devices market is projected to grow from $1.9 billion in 2024 to $3.0 billion in 2034. This represents a CAGR of 4.9%, reflecting rising demand across Cardiovascular Procedures, Minimally Invasive Surgeries and Diagnostic Procedures.

The Vascular Closure Devices market is set to add $1.2 billion between 2024 and 2034, with manufacturer targeting Radial Arterial Access & undefined Access projected to gain a larger market share.

With Growing incidences of cardiovascular diseases, and Technological advancements in vascular closure devices, Vascular Closure Devices market to expand 61% between 2024 and 2034.

Opportunities in the Vascular Closure Devices Market

Expanding Application in Emergency Care

The main use of closure devices is in surgical environments; nevertheless their potential in emergency situations as an immediate solution to control severe bleeding remains largely unexplored territory that could offer new possibilities for expanding the market for such devices, with additional research and advancements.

Personalized Vascular Closure Devices and Technological Innovations

The concept of medicine is gaining traction across different healthcare fields and could also be implemented in the Vascular Closure Devices market sector too. Since each patients anatomy and health status varies, customized vascular closure devices tailored to an individuals vascular structure and requirements have the potential to enhance procedure outcomes and reduce the chances of complications.

Cutting edge innovations such, as AI Robotics and the Internet of Medical Things have not only been fully harnessed in the development and use of Vascular Closure Devices yet. These advancements have the potential to improve accuracy levels significantly and reduce mistakes made by humans. Moreover they can also foresee patient results through data analysis techniques.

Growth Opportunities in North America and Europe

Europe Outlook

In the closure devices market in Europe is progressing after North America due to its strong healthcare system and the rising incidence of cardiovascular diseases present there as well as in North America Key industry players are engaged in significant investments to develop advanced technological devices Competition is intense as companies strive for innovation Opportunities, in this region arise from the increasing number of angiography procedures being conducted and the expanding elderly population

North America Outlook

In the market for vascular closure devices North America stands out with its high rate of invasive cardiology procedures advanced healthcare infrastructure and substantial investments in cutting edge medical technologies. Competition is fierce among leading companies that introduce innovative solutions. The potential for growth is evident, in the increasing number of individuals and the growing incidence of cardiovascular conditions.

North America Outlook

In the market for vascular closure devices North America stands out with its high rate of invasive cardiology procedures advanced healthcare infrastructure and substantial investments in cutting edge medical technologies. Competition is fierce among leading companies that introduce innovative solutions. The potential for growth is evident, in the increasing number of individuals and the growing incidence of cardiovascular conditions.

Europe Outlook

In the closure devices market in Europe is progressing after North America due to its strong healthcare system and the rising incidence of cardiovascular diseases present there as well as in North America Key industry players are engaged in significant investments to develop advanced technological devices Competition is intense as companies strive for innovation Opportunities, in this region arise from the increasing number of angiography procedures being conducted and the expanding elderly population

Growth Opportunities in North America and Europe

Established and Emerging Market's Growth Trend 2025–2034

1

Major Markets : United States, Germany, Japan, China, France are expected to grow at 3.4% to 4.5% CAGR

2

Emerging Markets : Brazil, India, South Africa are expected to grow at 5.4% to 6.9% CAGR

Market Analysis Chart

There are factors that drive the market for Vascular Closure Devices. The increasing incidence of diseases is a major driving force. As heart related ailments like strokes and coronary artery disease become more common the need for vascular closure devices is on the rise. Additionally the growing population of individuals, who are at higher risk, for cardiovascular issues is also contributing to the expansion of the market.

Recent Developments and Technological Advancement

December 2024

Medtronic unveiled a minimally invasive closure device called HemoSeal designed to shorten recovery time and enhance patient comfort during vascular procedures.

October 2024

St Jude Medical introduced a product called SealFast an innovative vascular closure device that offers improved clotting abilities and faster hemostasis gaining notable popularity in a relatively brief timeframe.

July 2024

Cardinal Health formed an alliance with a trailblazing company, in the field of vascular closure devices.

The market for closure devices has seen significant progress in the past few years with companies utilizing new technologies to introduce innovative products that offer better performance and user satisfaction. A notable development is the increasing preference, for invasive procedures that rely on vascular closure devices to achieve quick hemostasis and enhance patient comfort.

Impact of Industry Transitions on the Vascular Closure Devices Market

As a core segment of the Medical Device industry, the Vascular Closure Devices market develops in line with broader industry shifts. Over recent years, transitions such as Technological Advancements in Vascular Closure Devices and Shifting Patient Demographics and Lifestyle Diseases have redefined priorities across the Medical Device sector, influencing how the Vascular Closure Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

1

Technological Advancements in Vascular Closure Devices:

The Vascular Closure Devices market is experiencing changes because of advancements in technology. Creative solutions like approximators and passive sealants or collagen plugs are broadening the range of devices available and options for treatment resulting in better outcomes and faster recovery, for patients. These innovations are helping to grow the market. Are anticipated to fuel future expansion.

2

Shifting Patient Demographics and Lifestyle Diseases:

The evolving worldwide population trends and the rise in lifestyle related illnesses like heart conditions are affecting the market for closure devices significantly. This shift is defined by an increasing population that is more vulnerable to heart diseases and requires the utilization of vascular closure devices. The surge, in need is directly shaping the growth and advancement of the market.

Global Events Shaping Future Growth

The chart below highlights how external events including emerging market developments, regulatory changes, and technological disruptions, have added another layer of complexity to the Medical Device industry. These events have disrupted supply networks, changed consumption behavior, and reshaped growth patterns. Together with structural industry transitions, they demonstrate how changes within the Medical Device industry cascade into the Vascular Closure Devices market, setting the stage for its future growth trajectory.

Market Dynamics and Supply Chain

Driver: Growing Incidences of Cardiovascular Diseases, and Rise in Aging Population

The rising occurrence of heart related illnesses globally is also a driver for the expansion of the Vascular Closure Devices market as many of these conditions require surgical procedures and interventions that utilize vascular closure devices leading to an increased need, for them.
The increasing number of individuals worldwide is also playing a crucial role in driving the growth of the Vascular Closure Devices Market as older people are also at higher risk of developing cardiovascular conditions that necessitate vascular procedures and thus driving the demand, for closure devices for their treatment needs in the future.
Recent technological developments have also brought about creative vascular closure devices that aim to offer improved performance and safety, for both healthcare professionals and patients alike.

Restraint: Regulatory Challenges

A major obstacle in the Vascular Closure Devices market is navigating through obstacles due to these devices falling under medical regulations that impose stringent protocols for approval processes whenever changes or advancements are made to meet evolving health standards This may result in delays, in product launches and additional financial investments required for approvals which could impede the progress and adoption of new and enhanced devices thus restricting market expansion.

Challenge: High Product Cost

One significant challenge in the market is the pricing of Vascular Closure Devices which are often expensive because of the intricate manufacturing process involved and the requirements, for thorough testing to meet strict regulatory guidelines.

Supply Chain Landscape

Raw Material Suppliers

DuPont

DSM Biomedical

Component Manufacturers

Merit Medical Systems

B. Braun Melsungen

Vascular Closure Device Manufacturers
Abbott Laboratories / Terumo Corporation
End-User Industries
Healthcare / Cardiac Clinics / Multi-specialty Hospitals
Raw Material Suppliers

DuPont

DSM Biomedical

Component Manufacturers

Merit Medical Systems

B. Braun Melsungen

Vascular Closure Device Manufacturers

Abbott Laboratories

Terumo Corporation

End-User Industries

Healthcare

Cardiac Clinics

Multi-specialty Hospitals

Banner LogoBanner Logo

Leading Providers and Their Strategies

Application AreaIndustryLeadingProvidersProvider Strategies
Cardiac Procedures
Healthcare
Abbott Laboratories, Medtronic
Investing in continuous research and development for product innovation and improvements. These companies also focus on diverse portfolios to cater to various patient needs.
Vascular Surgery
Healthcare
Terumo Corporation, Cardinal Health
These providers are establishing strong relationships with medical professionals and healthcare organizations. They also focus on advanced product designs based on extensive market research and emerging surgical procedures.
Intervention Procedures
Healthcare
Teleflex Incorporated, Cardinal Health
The companies concentrate on creating cost-effective solutions to remain competitive in the market. They align their strategies towards addressing the needs of complex interventional procedures by providing versatile devices.

Elevate your strategic vision with in-depth analysis of key applications, leading market players, and their strategies. The report analyzes industry leaders' views and statements on the Vascular Closure Devices market's present and future growth.

Our research is created following strict editorial standards. See our Editorial Policy

Applications of Vascular Closure Devices in Minimally Invasive Surgeries, Diagnostic Procedures and Cardiovascular Procedures

Minimally Invasive Surgeries

Minimally invasive surgeries are more and more using VCDs these days due, to their ability to quickly stop bleeding and lower the risk of infections during the procedure This leads to hospital stays and better patient well being.

Diagnostic Procedures

The utilization of VCD s proves beneficial in diagnostic processes like angiography. By using these tools medical professionals can perform examinations with minimized chances of complications such as hematoma or pseudoaneurysms. The creative application of VCD s also provides the benefit of shorter post procedure bed rest. Cardinal Health and Medtronic are, at the forefront of utilizing VCD s in this manner.

Cardiovascular Procedures

The use of Vascular Closure Devices is incredibly important in heart procedures that involve catheterization techniques. They leverage cutting edge technology to help the artery heal quickly without the need for manual pressure application like before. One standout benefit of VCDs is their ability to shorten patient recovery times after a catheterization procedure. Key players in the market such as Terumo Corporation and Abbott are, at the forefront of offering these devices to enhance healing rates and overall patient satisfaction.

Vascular Closure Devices vs. Substitutes:
Performance and Positioning Analysis

After catheterization procedures for conditions vascular closure devices provide quick and effective hemostasis, outperform manual compression. Given the rising need for surgeries the market for VCDs has great potential, for growth.

Vascular Closure Devices
  • Hemostatic patches /
  • Percutaneous suture systems
    Rapid hemostasis, minimizes bleeding complications
    High cost, potential risk of vascular complications
    High level of safety and reliability, Less invasive treatment options
    Increased risk of bleeding, Lack of standardized usage guidelines

Vascular Closure Devices vs. Substitutes:
Performance and Positioning Analysis

Vascular Closure Devices

  • Rapid hemostasis, minimizes bleeding complications
  • High cost, potential risk of vascular complications

Hemostatic patches / Percutaneous suture systems

  • High level of safety and reliability, Less invasive treatment options
  • Increased risk of bleeding, Lack of standardized usage guidelines

After catheterization procedures for conditions vascular closure devices provide quick and effective hemostasis, outperform manual compression. Given the rising need for surgeries the market for VCDs has great potential, for growth.

Loading...

Research Methodology

This market research methodology defines the Vascular Closure Devices market scope, gathers reliable data, and validates findings using integrated primary and secondary research. Our systematic framework ensures precise market sizing, growth trend analysis, and competitive benchmarking.


Secondary Research Approach


We begin secondary research by defining the targeted market at Country and Regional levels. As part of the Medical Device ecosystem, we analyze Vascular Closure Devices across Hospitals, Ambulatory Surgical Centers, and Specialty Clinics Applications. Our team gathers data systematically from country level ministerial sources, industry associations & federations, trade databases, company annual & quarterly reports and other credential sources, enabling us to map global and regional market size, pricing trends, regulatory standards, and technology advancements.


Key Sources Referenced:


We benchmark competitors such as Abbott Laboratories, Medtronic Plc, and Terumo Corporation by reviewing company financial statements, and regulatory filings. Our secondary insights identify key market drivers and constraints, forming the analytical foundation for primary research.


Primary Research Methods


We conduct structured interviews and surveys with industry stakeholders, including Raw Material Suppliers, Component Manufacturers, and Vascular Closure Device Manufacturers. Our geographic coverage spans Americas (40%), Europe (30%), Asia-Pacific (25%) and Middle East & Africa (5%). Our online surveys generally achieve a response rate of above 65%, and telephone interviews yield 60%, resulting in above 92% confidence level with a ±7% margin of error.


Through targeted questionnaires and in-depth interviews, we capture purchase intent, adoption barriers, brand perception across Segment Type. We use interview guides to ensure consistency and anonymous survey options to mitigate response bias. These primary insights validate secondary findings and align market sizing with real-world conditions.


Market Engineering & Data Analysis Framework


Our data analysis framework integrates Top-Down, Bottom-Up, and Company Market Share approaches to estimate and project market size with precision.


Top-down & Bottom-Up Process


In Top-down approach, we disaggregate global Medical Device revenues to estimate the Vascular Closure Devices segment, using historical growth patterns to set baseline trends. Simultaneously, in Bottom-up approach, we aggregate Country-Level Demand Data to derive regional and global forecasts, which provide granular consumption insights. By reconciling both approaches, we ensure statistical precision and cross-validation accuracy.


We evaluate the supply chain, spanning Raw Material Suppliers (DuPont, DSM Biomedical), Component Manufacturers (Merit Medical Systems, B. Braun Melsungen), and Vascular Closure Device Manufacturers. Our parallel substitute analysis examines Hemostatic patches and Percutaneous suture systems, highlighting diversification opportunities and competitive risks.


Company Market Share & Benchmarking


We benchmark leading companies such as Abbott Laboratories, Medtronic Plc, and Terumo Corporation, analyzing their capabilities in pricing, product features, technology adoption, and distribution reach. By assessing company-level revenues and product portfolios, we derive market share comparisons, clarifying competitive positioning and growth trajectories across the ecosystem.


Our integration of data triangulation, supply chain evaluation, and company benchmarking, supported by our proprietary Directional Superposition methodology enables us to deliver precise forecasts and actionable strategic insights into the Vascular Closure Devices market.


Quality Assurance and Compliance


We cross-reference secondary data with primary inputs and external expert reviews to confirm consistency. Further, we use stratified sampling, anonymous surveys, third-party interviews, and time-based sampling to reduce bias and strengthen our results.


Our methodology is developed in alignment with ISO 20252 standards and ICC/ESOMAR guidelines for research ethics. The study methodology follows globally recognized frameworks such as ISO 20252 and ICC codes of practice.

rm

Vascular Closure Devices Market Data: Size, Segmentation & Growth Forecast

Report AttributeDetails
Market Value in 2025USD 2.0 billion
Revenue Forecast in 2034USD 3.0 billion
Growth RateCAGR of 4.9% from 2025 to 2034
Base Year for Estimation2024
Industry Revenue 20241.9 billion
Growth OpportunityUSD 1.2 billion
Historical Data2019 - 2023
Growth Projection / Forecast Period2025 - 2034
Market Size UnitsMarket Revenue in USD billion and Industry Statistics
Market Size 20241.9 billion USD
Market Size 20272.2 billion USD
Market Size 20292.4 billion USD
Market Size 20302.5 billion USD
Market Size 20343.0 billion USD
Market Size 20353.2 billion USD
Report CoverageMarket revenue for past 5 years and forecast for future 10 years, Competitive Analysis & Company Market Share, Strategic Insights & trends
Segments CoveredProduct Type, Access, End User, Procedure
Regional scopeNorth America, Europe, Asia Pacific, Latin America and Middle East & Africa
Country scopeU.S., Canada, Mexico, UK, Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, UAE and South Africa
Companies ProfiledAbbott Laboratories, Medtronic Plc, Terumo Corporation, Cardival Medical Inc, Merit Medical Systems Inc, W.L. Gore & Associates Inc, Becton Dickinson and Company, Boston Scientific Corporation, Essential Medical Inc, St. Jude Medical, Teleflex Incorporated and Vascular Solutions Inc.
CustomizationFree customization at segment, region or country scope and direct contact with report analyst team for 10 to 20 working hours for any additional niche requirement which is almost equivalent to 10% of report value

Explore Report Features and Data Packages

Industry Insight Report

$ 4200
Unlock Multi-User Access for just $999 more
i
No Payment Before Report Delivery
Flexible Payment Options
Additional Features
Customization Available
i
Excel Data Pack Included
Free Analyst Support
i
Industry Expert-Validated Insights
100% Confidentiality Guaranteed
Fast Delivery (24–72 hours)
i
Get Report Now

Strategic Growth Advisory

Unrivaled Custom Market Intelligence & Strategic Advisory for Business Growth and Competitive Excellence

  • Assess and prioritize high-value markets with precision
  • Craft tailored entry and expansion roadmaps
  • De-risk investments through rigorous market intelligence
  • Architect dynamic pricing frameworks aligned to value creation
  • Unlock sustainable margin enhancement opportunities
  • Benchmark performance against global industry leaders
  • Strategically realign portfolios to future growth drivers
  • Accelerate commercialization of breakthrough offerings
  • Harness market foresight and technology shifts to fuel innovation

Discover our Strategic Growth Advisory Services »

Table of Contents

Industry Insights Report - Table Of Contents

Chapter 1

Executive Summary

Major Markets & Their Performance - Statistical Snapshots

Chapter 2

Research Methodology

2.1Axioms & Postulates
2.2Market Introduction & Research MethodologyEstimation & Forecast Parameters / Major Databases & Sources
Chapter 3

Market Dynamics

3.1Market OverviewDrivers / Restraints / Opportunities / M4 Factors
3.2Market Trends
3.2.1Introduction & Narratives
3.2.2Market Trends - Impact Analysis(Short, Medium & Long Term Impacts)
3.3Supply Chain Analysis
3.4Porter's Five ForcesSuppliers & Buyers' Bargaining Power, Threat of Substitution & New Market Entrants, Competitive Rivalry
Chapter 4

Vascular Closure Devices Market Size, Opportunities & Strategic Insights, by Product Type

4.1Active Closure
4.2Passive Closure
Chapter 5

Vascular Closure Devices Market Size, Opportunities & Strategic Insights, by Access

5.1Femoral Arterial Access
5.2Radial Arterial Access
Chapter 6

Vascular Closure Devices Market Size, Opportunities & Strategic Insights, by End User

6.1Hospitals
6.2Ambulatory Surgical Centers
6.3Specialty Clinics
Chapter 7

Vascular Closure Devices Market Size, Opportunities & Strategic Insights, by Procedure

7.1Interventional Cardiology
7.2Interventional Radiology
Chapter 8

Vascular Closure Devices Market, by Region

8.1North America Vascular Closure Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.1.1U.S.
8.1.2Canada
8.2Europe Vascular Closure Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.2.1Germany
8.2.2France
8.2.3UK
8.2.4Italy
8.2.5The Netherlands
8.2.6Rest of EU
8.3Asia Pacific Vascular Closure Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.3.1China
8.3.2Japan
8.3.3South Korea
8.3.4India
8.3.5Australia
8.3.6Thailand
8.3.7Rest of APAC
8.4Middle East & Africa Vascular Closure Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.4.1Saudi Arabia
8.4.2United Arab Emirates
8.4.3South Africa
8.4.4Rest of MEA
8.5Latin America Vascular Closure Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.5.1Brazil
8.5.2Mexico
8.5.3Rest of LA
8.6CIS Vascular Closure Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.6.1Russia
8.6.2Rest of CIS
Chapter 9

Competitive Landscape

9.1Competitive Dashboard & Market Share Analysis
9.2Company Profiles (Overview, Financials, Developments, SWOT)
9.2.1Abbott Laboratories
9.2.2Medtronic Plc
9.2.3Terumo Corporation
9.2.4Cardival Medical Inc
9.2.5Merit Medical Systems Inc
9.2.6W.L. Gore & Associates Inc
9.2.7Becton Dickinson and Company
9.2.8Boston Scientific Corporation
9.2.9Essential Medical Inc
9.2.10St. Jude Medical
9.2.11Teleflex Incorporated
9.2.12Vascular Solutions Inc.